BTF3P8

Across TCGA pan-cancer cohorts, BTF3P8 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of BTF3P8’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where BTF3P8 RNA is repressed in tumor relative to normal tissue. In most cancer types BTF3P8 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD, LUAD, and KIRC are the cancer types where BTF3P8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BTF3P8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	−0.224	.002	4	view →
LUAD	All	All	+0.122	.002	3	view →
KIRC	All	II,III,IV	+0.046	.043	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

BTF3P8–STAD

Open the STAD breakdown →